On the basis of these findings, we assume that inhibition of HAUSP, important in the progression of glioma cell transformation, may block the tumorigenesis of gliomas, and targeting HAUSP may be an approach to improve the therapeutic intervention for poorly differentiated gliomas. The gene discussed is USP7; the disease is glioma.